Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Palmer

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
Diabetes Care|June 2, 2000
Therapeutic importance of subsets of type 2 diabetes?J P Palmer
The Journal of Clinical Investigation|July 4, 2001
Immunomodulatory therapy of human type 1 diabetes: lessons from the mouseJ P Palmer
Diabetes/Metabolism Reviews|October 1, 1987
Insulin autoantibodies: their role in the pathogenesis of IDDMJ P Palmer
Lancet (London, England)|June 4, 1994
What is the best way to predict IDDM?J P Palmer
Clinics in Endocrinology and Metabolism|July 1, 1983
Alcoholic ketoacidosis: clinical and laboratory presentation, pathophysiology and treatmentJ P Palmer
American Family Physician|July 1, 1980
Diabetic vascular disease and smokingP Hollander, J P Palmer
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 1, 1995
Recombinant human transforming growth factor beta does not inhibit the effects of interleukin-1 beta on pancreatic islet cellsW Hao, J P Palmer
Autoimmunity|March 3, 1999
Type 1 1/2 diabetes: myth or reality?R Juneja, J P Palmer
Autoimmunity|January 1, 1995
The effect of cytokines on expression of glutamic acid decarboxylase-65 in cultured isletsW Hao, J P Palmer
Diabetologia|March 26, 2010
Latent autoimmune diabetes in adults (LADA) is dead: long live autoimmune diabetes!O Rolandsson, J P Palmer
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
Diabetes Care|June 2, 2000
Therapeutic importance of subsets of type 2 diabetes?J P Palmer
The Journal of Clinical Investigation|July 4, 2001
Immunomodulatory therapy of human type 1 diabetes: lessons from the mouseJ P Palmer
Diabetes/Metabolism Reviews|October 1, 1987
Insulin autoantibodies: their role in the pathogenesis of IDDMJ P Palmer
Lancet (London, England)|June 4, 1994
What is the best way to predict IDDM?J P Palmer
Clinics in Endocrinology and Metabolism|July 1, 1983
Alcoholic ketoacidosis: clinical and laboratory presentation, pathophysiology and treatmentJ P Palmer
American Family Physician|July 1, 1980
Diabetic vascular disease and smokingP Hollander, J P Palmer
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 1, 1995
Recombinant human transforming growth factor beta does not inhibit the effects of interleukin-1 beta on pancreatic islet cellsW Hao, J P Palmer
Autoimmunity|March 3, 1999
Type 1 1/2 diabetes: myth or reality?R Juneja, J P Palmer
Autoimmunity|January 1, 1995
The effect of cytokines on expression of glutamic acid decarboxylase-65 in cultured isletsW Hao, J P Palmer
Diabetologia|March 26, 2010
Latent autoimmune diabetes in adults (LADA) is dead: long live autoimmune diabetes!O Rolandsson, J P Palmer
Pageof 14